4-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-2-nitro-phenylamine → 4-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-benzene-1,2-diamine

HRID 1513236Notes

Reaction equation

HRID 1513236 reaction equation
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:18]=[CH:17][C:16]([NH2:19])=[C:15]([N+:20]([O-])=O)[CH:14]=3)=[N:10][N:9]=2)=[CH:4][CH:3]=1>C1COCC1.CCO>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[O:12][C:11]([C:13]3[CH:14]=[C:15]([NH2:20])[C:16]([NH2:19])=[CH:17][CH:18]=3)=[N:10][N:9]=2)=[CH:6][CH:7]=1

Participants

3

Procedure

To a 25 mL rbf was added 0.4137 g (1.31 mmol) of 4-[5-(4-Chloro-phenyl)-[1,3,4]oxadiazol-2-yl]-2-nitro-phenylamine, 4 mL of THF/EtOH (1:1). Vacuum flushed 3×, then added 0.1655 g of PtO2 (40% by weight) as a slurry in 2 mL of THF/EtOH (1:1). It was flushed with H2 3× and allowed to stir at r.t. for 18 h. 10 ml DCM and Celite was added and it was let stir 1 h. The mixture was then filtered through Celite pad, and the filter cake was rinsed with 20 mL DCM. The filtrate was reduced in vacuo to give the title compound. 1H NMR (400 MHz, DMSO-d6) δ ppm 4.85 (br. s., 1.7 H) 5.31 (br. s., 1.7 H) 6.62 (d, J=8.08 Hz, 1 H) 7.19 (dd, J=8.08, 1.89 Hz, 1 H) 7.26 (d, J=2.02 Hz, 1H) 7.66-7.70 (m, 2 H) 8.02-8.06 (m, 2 H). MS (m/z) 287.2 M (+1), tR=1.18, Meth 10

Workup

  1. customVacuum flushed 3×
  2. additionadded 0.1655 g of PtO2 (40% by weight) as a slurry in 2 mL of THF/EtOH (1:1)
  3. customIt was flushed with H2 3×
  4. addition10 ml DCM and Celite was added
  5. stirringit was let stir 1 h
  6. filtrationThe mixture was then filtered through Celite pad
  7. washthe filter cake was rinsed with 20 mL DCM

Sources & evidence

ORD record
ord-ce0340412b5e4e27ab0d694c6eaf42ac
Source dataset
uspto-grants-2012_07
Patent number
US08217065B2

Reaction notes

Loading…